We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Denison Mines
DNN
$2.91B
| $577K | ﹤0.01% |
295,733
+146,798
| +99% | +$278K |
|
2227
Third Coast Bancshares
TCBX
$738M
| $576K | ﹤0.01% |
28,760
+16,881
| +142% | +$327K |
|
2228
Magnite
MGNI
$3.55B
| $573K | ﹤0.01% |
53,261
+32,033
| +151% | +$320K |
|
2229
Photronics
PLAB
$1.93B
| $572K | ﹤0.01% |
20,200
-92,482
| -82% | -$2.75M |
|
2230
MKS Inc
MKSI
$20.6B
| $572K | ﹤0.01% |
4,300
-29,880
| -87% | -$3.47M |
|
2231
Forum Energy Technologies
FET
$835M
| $569K | ﹤0.01% |
28,484
-4,235
| -13% | -$83.5K |
|
2232
GrowGeneration
GRWG
$90.7M
| $568K | ﹤0.01% |
198,729
+137,019
| +222% | +$316K |
|
2233
StealthGas
GASS
$319M
| $567K | ﹤0.01% |
95,415
-72,483
| -43% | -$488K |
|
2234
Tenaya Therapeutics
TNYA
$163M
| $567K | ﹤0.01% |
108,345
-81,536
| -43% | -$390K |
|
2235
RenaissanceRe
RNR
$13.4B
| $565K | ﹤0.01% |
2,404
+4
| +0.2% | +$888 |
|
2236
Oceaneering
OII
$4.77B
| $564K | ﹤0.01% |
24,111
-58,989
| -71% | -$1.24M |
|
|
TRML
2237
DELISTED
Tourmaline Bio
TRML
| $562K | ﹤0.01% |
24,547
-31,816
| -56% | -$1.12M |
|
2238
PUT
Bloom Energy
BE
$64.6B
| $562K | ﹤0.01% |
50,000
-876,700
| -95% | -$9.64M |
|
2239
Enerpac Tool Group
EPAC
$1.93B
| $560K | ﹤0.01% |
15,714
-39,483
| -72% | -$1.27M |
|
2240
Trade Desk
TTD
$6.49B
| $559K | ﹤0.01% |
+6,400
| New | +$485K |
|
|
ESGR
2241
DELISTED
Enstar Group
ESGR
| $559K | ﹤0.01% |
1,800
| – | – |
|
2242
Energizer
ENR
$1.55B
| $558K | ﹤0.01% |
18,942
-9,858
| -34% | -$298K |
|
|
AY
2243
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $557K | ﹤0.01% |
30,151
+3,350
| +12% | +$63.1K |
|
2244
eGain
EGAN
$201M
| $556K | ﹤0.01% |
86,277
-7,963
| -8% | -$54.6K |
|
|
INFN
2245
DELISTED
Infinera Corporation Common Stock
INFN
| $556K | ﹤0.01% |
92,224
-516,280
| -85% | -$2.59M |
|
2246
CALL
Acadia Pharmaceuticals
ACAD
$5.03B
| $555K | ﹤0.01% |
+30,000
| New | +$743K |
|
2247
Sonoco
SON
$5.74B
| $554K | ﹤0.01% |
9,584
-103,380
| -92% | -$5.9M |
|
2248
CytomX Therapeutics
CTMX
$754M
| $553K | ﹤0.01% |
253,773
+239,632
| +1,695% | +$442K |
|
2249
Southern Missouri Bancorp
SMBC
$850M
| $552K | ﹤0.01% |
12,619
+3,666
| +41% | +$165K |
|
|
DAY
2250
DELISTED
Dayforce
DAY
| $550K | ﹤0.01% |
8,300
-100
| -1% | -$6.83K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.